SILICON LABORATORIES INC
For the period ended Jun 29, 2024. Filed Jul 24, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 29, 2024 · Filed Jul 24, 2024
SLAB$221.61-0.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets at and
Condensed Consolidated Balance Sheets
(In thousands, except per share data)
| June 29,2024 | December 30,2023 | |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $240,834 | $227,504 |
| Short-term investments | 98,336 | 211,720 |
| Accounts receivable, net | 41,212 | 29,295 |
| Inventories | 166,079 | 194,295 |
| Prepaid expenses and other current assets | 53,585 | 75,117 |
| Total current assets | 600,046 | 737,931 |
| Property and equipment, net | 139,397 | 145,890 |
| Goodwill | 376,389 | 376,389 |
| Other intangible assets, net | 47,374 | 59,533 |
| Other assets, net | 86,781 | 123,313 |
| Total assets | $1,249,987 | $1,443,056 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $39,295 | $57,498 |
| Revolving line of credit | — | 45,000 |
| Deferred revenue and returns liability | 3,323 | 2,117 |
| Other current liabilities | 57,495 | 58,955 |
| Total current liabilities | 100,113 | 163,570 |
| Other non-current liabilities | 56,845 | 70,804 |
| Total liabilities | 156,958 | 234,374 |
| Commitments and contingencies | ||
| Stockholders’ equity: | ||
| Preferred stock – $0.0001 par value; 10,000 shares authorized; no shares issued | — | — |
| Common stock – $0.0001 par value; 250,000 shares authorized; 32,289 and 31,897 shares issued and outstanding at June 29, 2024 and December 30, 2023, respectively | 3 | 3 |
| Additional paid-in capital | 39,232 | 16,973 |
| Retained earnings | 1,054,048 | 1,192,731 |
| Accumulated other comprehensive loss | (254) | (1,025) |
| Total stockholders’ equity | 1,093,029 | 1,208,682 |
| Total liabilities and stockholders’ equity | $1,249,987 | $1,443,056 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.